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OUTBREAK INVESTIGATIONSP 13-1
SPOTS AND DOTS: WHEN OUTBREAK INVESTIGATION MEETS “REALITY”
Paul Anantharajah Tambyah. Department of Medicine, National University
of Singapore, Singapore
Measles is an important vaccine preventable illness that unfortunately has
re-emerged in recent years for a variety of reasons including anxiety about
vaccination, inadequate vaccine regimes in many countries which still used a
one dose regime as well as the limitations of currently available MMR
vaccines. It is highly transmissible as an airborne disease and can have
atypical presentations in immunocompromised children and adults. It can
spread rapidly in naı¨ve populations and have a serious impact with a
significant morbidity and even mortality. Outbreaks in institutions are not
unknown and present many unique challenges.
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WHEN IS AN OUTBREAK NOT AN OUTBREAK?
Robert A. Weinstein, M.D. Cook County Hospital and Rush University Medical
Center, United States
The seven major steps in outbreak investigation begin with establishing the
existence of an outbreak, i.e., has an outbreak actually occurred; followed by
verifying thediagnoses; doing a case count; orienting data into time, place, and
person; determining the size of the population at risk; developing hypotheses
about the causal factors that led to theoutbreak; and testing those hypotheses.
A key and powerful tool in outbreak evaluation is the epidemic curve from
which many aspects of the epidemiology of the events can be inferred.
Testing causation hypotheses often depends on a case-control study and
increasingly on use of advanced molecular diagnostics to compare outbreak
isolates.
In many instances, 11% in one study, this step-wise approach discloses that
apparent outbreaks are pseudo-epidemics. The most common problems that
have led to pseudo-epidemics have been specimen processing errors,
surveillance artifacts, or clinical misdiagnoses.SP 13-3
MYCOBACTERIUM ABSCESSUS SUBSPECIES MASSILIENSE: AN EMERGING
HEALTHCARE ASSOCIATED PATHOGEN
Aristine Cheng a,b, Wang-Huei Sheng b, Yhu-Chering Huang c, Hsin-
Yun Sun b, Yu-Chung Chuang b, Mei-Lin Chen b, Ying-Chieh Liu b, Yi-
Tzu Tsai b, Po-Ren Hsueh b, Chien-Ching Hung b, Yee-Chun Chen b, Shang-
Chwen Chang b. aNational Taiwan University Hospital, Hsinchu Branch,
Hsinchu City, Taiwan; bNational Taiwan University Hospital, Main Branch,
and National Taiwan College of Medicine, Taipei, Taiwan; cChang Gung
Medical Hospital and Chang Gung University College of Medicine, Taoyuan,
Taiwan
Reports regarding human infections by Mycobacterium abscessus subspecies
massiliense, also known as M. abscessus subspecies bolletii, a subspecies of
the rapidly growing mycobacteria, M. abscessus, have increased since it was
first named in 2004. This emerging pathogen is likely to be under-recognized
since it cannot be identified by conventional methods. However, many mo-
lecular-based studies indicate that this entity is clinically important, highly
resistant to disinfectants, multiply drug resistant, perhaps more transmis-
sible and virulent than M. abscessus sensu stricto. Unusually, a single strain
of M. abscessus subspecies massiliense (BRA 100) has been responsible for an
epidemic of post-surgical infections in Brazil with at least 2032 notified cases
in 63 hospitals across seven regions reported between 2004 and 2010. The
same subspecies has also caused widespread respiratory outbreaks among
cystic fibrosis cohorts in the United States and the United Kingdom. Notably,
high genetic relatedness between these intercontinental outbreak strains, in
contrast to the diversity of environmental NTM, suggest that they may be
more transmissible, whether from a common source, as in soft tissue infec-
tions or from patient-to-patient (directly or indirectly as perhaps in respira-
tory outbreaks). Similarly in Taiwan, outbreaks of post-procedural infectionsby M. abscessus subspecies massiliense, with a seemingly predominant strain
(TPE 101) have emerged.
This lecture reviews the global and local epidemiology of this emerging
healthcare associated pathogen.
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IT COMES WITH WATER
Anucha Apisarnthanarak, M.D. Thammasat University Hospital, Thailand
The complexity of modern healthcare facilities and increasing proportion of
immunologically vulnerable patients make prevention of healthcare-associ-
ated waterborne infections a high priority. Several factors make hospital
buildings suitable for colonization with bacteria and molds: large, complex
water systems with areas of low flow predispose to stagnation and biofilm
formation; water temperatures that are optimal for healthcare use may also
be ideal for bacterial growth. Nursing staff should pay special attention to
children and immunosuppressed patients in terms of tap-water exposure and
also their personal hygiene, and should regularly use sterile water for rinsing/
cleaning devices. In this session, I will discuss the outbreak associated with
water-borne infections in healthcare setting in non-disaster and disaster
related situation. Their preventive measures will also be discussed.SYMPOSIUM 14 (SP 14)
CURRENT LABORATORYMETHODS FOREPIDEMIOLOGICAL INVESTIGATION
DURING NOSOCOMIAL OUTBREAKSP 14-1
LABORATORY METHODS TO SUPPORT EPIDEMIOLOGICAL
INVESTIGATIONS DURING OUTBREAKS
Allen C. Cheng. Infection Prevention and Healthcare Epidemiology Unit,
Alfred Health, Department of Epidemiology and Preventive Medicine,
Monash University, Australia
Typing of bacterial species may be useful to infer transmission, just as
fingerprinting may help place suspects at the scene of a crime. The choice of
method to distinguish between bacterial strains depends on the degree of
resolution required, the resources available and the implications for control
measures. Issues can arise when outbreaks involve the horizontal trans-
mission of genetic material, rather than organisms.
An ideal typing method would be cheap, rapid, reproducible and comparable
between labs, and widely available. For most organisms, older phenotypic
methods to discriminate between strains have generally been supplanted by
genotypic methods. Many genotypic methods exist that distinguish between
strains on the basis of genetic variation either directly (based on sequences)
or indirectly (based in binding to restriction enzymes). However, these
methods must be considered in the context of the background genetic
diversity of the organism, and the reproducibility between laboratories.
The advent of rapid whole genome sequencing at low cost has revolutionized
this field, by providing unprecedented typing resolution and reliability,
although some issues remain in bioinformatics capacity. However, diagnostic
tests that no longer rely on the isolation of an organism in culture may
paradoxically hamper outbreak investigations.SP 14-2
MALDI-TOF MS-BASED SPECIES IDENTIFICATION AND TYPING
APPROACHES IN MYCOBACTERIA
Shang-Chen Hsieh a, Chih-Cheng Su b, Jang-Jih Lu a,c, Hsin-Chih Lai a,c,*.
aGraduate Institute of Medical Biotechnology and Laboratory Science,
College of Medicine, Chang-Gung University, No. 259, Wenhua 1st Rd.,
Gueishan Township, Taoyuan, Taiwan; bInstitute of Microbiology and
Immunology, National Yang-Ming University, No. 155, Sec. 2, Linong St.,
Taipei, Taiwan; cDepartment of Laboratory Medicine, Chang Gung Memorial
Hospital at Linkou, Taoyuan, Taiwan
Rapid and accurate discrimination between non-tuberculosis mycobacteria
(NTM) are essential for appropriate therapeutic management and timely
